Background: Autologous fat grafting (AFG) is increasingly used in cosmetic surgery. However, its efficacy and safety are still ambiguous. Both a comprehensive overview and recapitulation of the relevant literature provide current evidence on the efficacy and outcomes of AFG in cosmetic breast surgery. Objectives: This review provides an up-to-date overview of the literature on AFG in cosmetic breast augmentation. Methods: A systematic review of the literature on AFG used for cosmetic breast augmentation was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. This study included selected studies that were published between January 1996 and February 2016 and reported on 10 patients or more who had a minimal mean follow-up period of 1 year. Results: In this study, 22 articles that reported on 3565 patients with follow-up periods ranging from 12 to 136 months were included. A complication rate of 17.2% (95% CI 15.9-18.5) was seen. Indurations were the most frequent complication (33.3%, 95% CI 20.4-46.3), followed by persistent pain (25%, 95% CI 0.5-49.5), and hematoma (16.4%, 95% CI 14.5-18.4). Mammograms revealed micro-calcifications (9.0%, 95% CI 6.4-11.5) and macrocalcifications (7.0%, 95% CI 3.8-10.2). The mean volume retention was 62.4% (range, 44.7-82.6%), with a satisfaction rate of 92% in patients and 89% in surgeons. Conclusions: AFG is a promising method in achieving autologous cosmetic breast augmentation with satisfactory volume retention and satisfaction rates in eight and six studies, respectively. Complications and radiological findings are comparable to those after implant augmentation. Future studies should focus on cancer occurrence and detection to further substantiate AFG safety. In addition, grafting methods and the use of auxiliary procedures to identify factors leading to better outcomes in terms of volume retention should be investigated. Finally, objective questionnaires are needed to represent patient satisfaction.
Autologous fat grafting (AFG) is becoming an increasingly popular procedure in cosmetic surgery. With this growing popularity, the technique has been gaining acceptance for use with cosmetic breast augmentation. However, the number of questions regarding the optimal methods for fat harvesting, processing, and injecting is also increasing, as reflected by the recent paper by Longaker et al. 1 The systematic review of Strong et al 2 recently showed higher retention rates in human studies with centrifugation, as opposed to sedimentation, and slower reinjection rates into less mobile areas. However, this same advantage could not be found in experimental animal studies and in vitro analyses. Until recently, AFG in breast augmentation was limited by the amount of fat that could be transferred to the different compartments and the increased absorption when exceeding that amount. Recent retrospective studies on larger-volume AFG in combination with compartment-expanding techniques, such as the Breast Enhancement and Shaping System (BRAVA), have shown encouraging results; [3] [4] [5] [6] prospective trials are currently being conducted. 7 Further positive results are expected from the use of supplementation with platelet-rich plasma (PRP), which is showing improved neovascularization and long-term graft retention in experimental animal studies. 8, 9 Furthermore, stromal vascular fraction (SVF) seems to increase the quantity of adipose-derived stem cells (ASCs) in the graft, [10] [11] [12] thereby promoting adipose regeneration, angiogenesis, and release of angiogenic growth factors. 13, 14 In addition, the fear that the procedure interferes with cancer diagnostics and that it may promote cancer is gradually diminishing, 15 which is supported by studies reporting on the safety of the technique. [16] [17] [18] As the outcomes of AFG in cosmetic breast reconstruction seem encouraging, and with its rise in popularity, it is important to assess the available evidence on the safety and efficacy of the technique. This realization is shown in the number of recently published systematic reviews on the subject with Strong et al, 2 Largo et al, 19 and Voglimacci et al. 20 These reviews add greatly to the comprehensive overview of the current evidence on the safety, technique, efficacy, and patientreported outcomes. The first review by Strong et al 2 gives a thorough descriptive analysis of the articles that focus on technique-specific aspects, such as harvest site ( preparation), adipose tissue isolation, and injection techniques, as well as instruments, without looking at the specific AFG indications. The second review by Largo et al, 19 while maintaining a methodology similar to the current review and reporting on comparable outcomes, includes 36 articles up to December 31 2012, covering 1453 patients. This is less than half of the current study population covered in 22 articles. The inclusion of low-level case reports/series causes a high level of heterogeneity between the studies that already report very differently on the important technical aspects that were previously mentioned. The same methodological choice regarding the inclusion of case reports/studies is found in the review by Voglimacci et al. While this report provides an update of the included articles up to July 2014, it also omits important tables on certain outcomes, such as radiological appearances and complications. The authors believe that the inclusion of such tables increases the readability. Finally, the follow-up periods of the included studies were not reported in the review by Strong et al. 2 These follow-up periods ranged from 1 to 156 months and 6 to 156 months in the reviews of Largo et al 19 and Voglimacci et al, 20 respectively. It is known that fat retention can take 3 to 6 months before reaching a steady state, [21] [22] [23] so it is essential to maintain a longer follow-up period. Therefore, our primary aim was to give an updated comprehensive overview regarding safety, technique, efficacy, and patient-/surgeon-reported outcomes of AFG for breast augmentation purposes. Our minimal sample size was 10 patients, and the mean follow-up period was at least 1 year after the last fat grafting session. By including studies up to February 20 2016, we included three new articles, [24] [25] [26] one of which practiced high-volume grafting (range, 300-600 cc) and one of which added to the number of BRAVA-prepared patients. The authors believe this can add value to this paper in comparison to previous reviews. Our secondary aim was to reveal deficiencies in the current literature, which may form the basis for further research.
The research questions were as follows:
(1) In regard to women seeking cosmetic breast augmentation (P), can the use of Autologous Fat Grafting (I) provide a safe (oncologically, radiologically, and in regard to complications such as bleeding, infection and postoperative pain) and effective (adequate volume retention, esthetic effect, and patient satisfaction) alternative or addition (O) to other forms of breast augmentation (with implants) (C)? (2) In regard to women seeking alternative or additional methods for cosmetic breast augmentation with the use of Autologous Fat Grafting (P), can an extensive systematic review, which includes articles up to 2016 that have a 10-patient minimal sample size and mean follow-up period of 1 year (I), reveal new deficiencies in the current literature (O) in comparison to previously published studies (C)?
METHODS
This is a systematic review of the literature reporting on AFG used for augmentation of the female breast conducted according to the PRISMA statement. 27 A completed PRISMA checklist is available as Supplementary Material at www. aestheticsurgeryjournal.com. A systematic review conducted by the same authors using a similar methodology but reporting on AFG used in addition to onco-plastic breast reconstruction was recently published. 28 The PubMed, Embase. com, Wiley/Cochrane Library, and Web of Science databases were searched from inception (by JG and JCFK) up to the final screening on February 20 2016. The following terms were used (including synonyms and closely related words) as index terms or free-text words: "fat" or "adipocyte" or "lipo" and "grafting" or "filling" or "transplant." The full search strategies for all of the databases is available as Supplementary Material at www.aestheticsurgeryjournal. com. Studies that were considered potentially relevant based on the titles were stored using the RefWorks database. There was no restriction on language, type of study, or publication media. Bibliographies of the retrieved articles were manually searched for relevant and possibly missed references.
Eligibility Criteria
Original articles regarding the application of fat grafting (with or without supplementation) in cosmetic breast augmentation were found to be eligible for inclusion. In addition, all harvesting, processing, and injecting techniques were found to be eligible for this study. The articles were collected by two independent reviewers ( JG and VN) and screened on the outcomes, including complications, radiological appearances, volume retention, fat grafting technique, and patient/surgeon satisfaction. Duplicate articles, case reports, or case series with a sample size <10 and articles with a mean follow-up period <12 months were excluded.
Study Selection
The abstracts of the selected studies were evaluated independently by two researchers ( JG and VN). When found eligible by both reviewers, the full text article was retrieved for evaluation, data extraction, and inclusion in the systematic review. Discrepancies between the two reviewers were discussed, and if a solution was not found, a third reviewer (MM) was consulted. When a study could not be retrieved from the electronic media or the local library, the authors were contacted to request a copy.
Outcome Measures
We included the following outcomes:
(1) Complications: type and frequency of complications. 
Data Collection Process
Data were extracted by one researcher ( JG) using standardized tables developed for this purpose and checked by a second reviewer (VN). Data extracted from each article included authors, date of publication, number of subjects, indication for the procedure, type of study, technique used for adipocyte implantation, follow-up time, efficacy of treatment, patient satisfaction, clinical complications, and volume retention radiographic changes. Randomized controlled trials (RCTs), prospective and retrospective observational or comparative cohort studies, and case series with a sufficient sample size and follow-up were evaluated with respect to the following factors: clear description of inclusion and exclusion criteria, method of patient selection for the procedure (ie, consecutive vs nonconsecutive recruitment), adequate sample size (> 10 patients), use of objective outcomes, and sufficient duration of follow-up period. Included studies were assigned a level of evidence according to the Oxford Centre for Evidence-Based Medicine (2011) by two independent reviewers ( JG and VN). Discrepancies in scoring were discussed by all reviewers. The principal summary measures are means over follow-up periods and percentages with an actual number given between parentheses.
Statistical Analysis
The data were pooled to calculate the overall proportion with a 95% confidence interval. Due to insufficient data reported, statistical analyses of the fat grafting technique, volume retention, and patient and surgeon satisfaction could not be performed. To compare the harvesting methods in regard to volume retention, we used the Mann-Whitney U test for abnormally distributed data (Kolmogorov-Smirnov test). The Cohen's kappa coefficient was used to calculate the inter-rating observer variability of the selected articles.
Risk of Bias Across Studies
Observational studies and clinical trials without detailed randomization protocols were considered studies with a high risk of bias. A Cochrane Risk of Bias Assessment Tool: for Non-Randomized Studies of Interventions (ACROBAT-NRSI) was used for quantifying the risk of bias across the studies. A sensitivity analysis was not performed because the two studies that were considered to have a serious risk of bias 26, 29 consisted of a total cohort of 24 patients.
RESULTS
There was a high inter-rater agreement in selecting relevant articles based on the abstract screening of 0.79. There was no difference between the reviewers regarding data extraction. After screening (Figure 1 ), a total of 23 articles was included. [4] [5] [6] [10] [11] [12] 21, [24] [25] [26] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] All of the articles were English-written articles. The risk of bias across the studies (Table 1) was measured using ACROBAT-NRSI 42 
Postoperative Management
Out of the 22 studies, 10 of them reported on postoperative management. 4, 5, 21, 24, 30, 31, 33, [39] [40] [41] Two studies reported postoperative medicinal regiments, 21, 30 with both studies prescribing an unspecified kind of analgesic next to one study prescribing an unspecified kind of antibiotic and sleeping pill. Nine studies 4, 5, 24, 30, 31, 33, [39] [40] [41] reported using some postoperative protective or supportive types of breast garments, ranging in use from 1 day to 6 weeks. One study 41 reported using no garments, while one study 40 used local cold compresses only with suspected edema or inflammation. Two studies reported on the postoperative management of the donor site. 21, 24 Of these studies, one used an abdominal support belt for 6 weeks next to endermology consultation when suspecting edema, and one study used compressive garments not further specified. Postoperative instructions were reported in three studies. 21, 39, 40 These instructions included harvest site massage instructions in one study and avoidance of breast compression for approximately 4 months, in the two additional studies.
39,40

Complications
In a total of 17 studies, [4] [5] [6] 10, 21, [24] [25] [26] [29] [30] [31] [36] [37] [38] 40, 41, 43 an analysis showed an overall complication rate of 17.2% (95% CI 15.9-18.5) after a mean follow-up period of 34.5 months in 3409 patients after AFG for cosmetic purposes ( Table 3) . The following are complication rates over the total of patients from the studies that reported on that specific complication. Palpable indurations were seen in 33.3% (95% CI 20.4-46.3) of the cases. 25, 26, 29 Persistent pain was reported in one study 29 in 25.0% of the patients (95% CI 0.5-49.5). A hematoma was seen in 16.4% (95% CI 14.5-18.4) of the patients. 4, 30, 33, 37, 38 New nodules were reported in 11.0% (95% CI 8.6-13.4) of the cases, and cytological analyses of the aspirated or surgically removed material showed fat necrosis in all cases. 5, 6, 36, 40 In 8.3% (95% CI 0.0-42.9) of the patients, abnormal breast fluid, lymphadenopathy, and pus discharge were seen. 29 Other complications were dysesthesia in 7.7% (95% CI 3.8 11.6), 4 fat necrosis in 6.6% (95% CI 5.5-7.7), 4, 6, 10, 21, 25, 31, 36, 40 and calcifications in 4.47% (95% CI 2.8-6.6) 10,25,40 of the cases. Striae of the breast were seen in 4.3% (95% CI 3.0-5.6) 30, 33 and cyst formation in 3.3% (95% CI 1.9-4.7) of the cases. 4, 24, 31, 38, 40 Infection of the breast was seen and treated with oral antibiotics, drainage, and/or ice packing in 0.9% (95% CI (0.5-1.2) 6, 10, 21, [24] [25] [26] 29, 33, 37, 38 of the cases, and donor site infection was seen in 0.6% (95% CI 0.0-3.9) of the cases. 5, 24 Donor site deformation was seen in 0.4% (95% CI 0.0-2.3) 24, 38 of the cases; pneumothorax, another rare complication, was seen in two patients 6, 21, 24, 37 
Radiological Follow-Up
Radiological images after AFG were studied in 19 articles (Table 4) . [4] [5] [6] 10, 21, 24, 26, [30] [31] [32] [34] [35] [36] [37] [38] 40, 41, 43, 45 One study was excluded because it reported the outcomes per image instead of the outcomes per patient. 11 The majority of the studies used standard pre-and postoperative mammograms to report on the radiological images (11 studies, n = 1912), [4] [5] [6] 21, 24, 30, 32, 34, 35, 37, 38 with three studies (n = 692) reporting Breast Imaging Reporting and Data System (BIRADS) outcomes only. 26, 33, 36 Some studies looked also at sonograms (4 studies, n = 544) or MRIs (5 studies, n = 305). Fat necrosis was reported in 14.0% (95% CI 11.4-16.6) of the cases on mammogram, 4 
Fat Grafting Technique
Twenty-one articles described, to some extent, the methods of preparing and grafting the adipose tissue (Table 5) . [4] [5] [6] 10, 11, 21, [24] [25] [26] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] The anesthetic method was reported in 11 studies, with 8 studies using general anesthesia, 4, 11, 21, 24, 30, 37, 40, 41 2 studies adding local anesthesia, 10, 25 and 1 study using just a local form of anesthesia. 35 The abdomen was the primary donor site in most studies. Fat from the gluteal area or the arms was used in cases of insufficient supply or an odd fat distribution. For harvesting, most authors described performing manual aspiration, usually with a 2-to 4-mm cannula attached to a 1-to 60-cc syringe. The majority of the studies applied centrifugation on 3000 rpm for periods ranging from 4 to 5 minutes. Four studies [4] [5] [6] 26 combined AFG with the pre-and postoperative use of the BRAVA system, and one study 39 used only the device 3 weeks preoperatively. Five studies reported the use of supplements, which were composed of PRP 30, 41 or SVF. 10, 25, 45 For the injections, most studies described using a multiplane, retrograde (on withdrawal) injection technique. The primary site of injection was the subcutaneous space with additional injections most often performed into the subpectoral and retroglandular spaces. The number of sessions for delivering AFG to achieve a satisfactory result was reported in 14 studies [4] [5] [6] 24, 26, 30, 31, 33, 34, [36] [37] [38] [39] [40] and varied from one to three sessions (ie, 1 session for 1190 patients, 2 sessions for 127 patients, and 3 sessions for 32 patients). No significant associations were found between the volume of the initial fat graft and the number of sessions or CR, critical risk of bias (the study is too problematic to provide any useful evidence on the effects of intervention); LR, low risk of bias (the study is comparable to a well-performed randomized trial with regard to this domain); MR, moderate risk of bias (the study is sound for a nonrandomized study with regard to this domain but cannot be considered comparable to a well-performed randomized trial); NI, no information on which to base a judgment about the risk of bias for this domain; SR, serious risk of bias (the study has some important problems).
between the form of augmentation and the number of sessions.
Volume Retention
In addition to patient satisfaction, objective measurements of the volumetric result, by way of a reliable volumetric analysis, are imperative to demonstrate the efficacy of AFG. Recently, more sophisticated ways of measuring have been used, such as specified 3D measuring systems or MRI analyses. Eight studies with a total of 523 patients complied with the inclusion criteria of sufficient sample size and follow-up period and were included in the final analysis (Table 6) . 5, 6, 25, 26, 30, 36, 38, 39 Four studies 5, 6, 26, 36 used MRIs, and three studies used advanced 3D measuring systems; one study combined an MRI and 3D measurements, 36, 38, 39 and one study used volumetric measurement. 30 Additionally, one study measured volume retention through the difference in breast thickness, by way of a sonogram, at the 3 o'clock and 9 o'clock periareolar points between implant removal and 1 year after additional AFG. 25 Five of the eight studies (n = 419) 5,6,36,38,39 described a mean total preoperative volume of 225.26 mL. The mean total injected volume per breast was 339 cc in seven studies (n = 458) 5, 6, 25, 26, 36, 38, 39 and the mean volume gain per breast as described in six studies (n = 431) 5, 6, 26, 36, 38, 39 was 216.2 cc over a minimal period of 1 postoperative year. The retention of injected fat over a total of eight studies was 62.4% (range, 44.7-82.6%), with an average follow-up period of 16.6 months (range, 12-120). When correcting for important technical variables like preparation and the use of supplementation, there was 60.9% volume retention in the seven studies 5, 6, 25, 26, 36, 38, 39 (n = 458) that used centrifugation (range, 15-1200 g or 3000 rpm for 2-4 min) as form of preparation. Furthermore, a 67.9% retention rate was found in the four studies 5, 6, 26, 39 (n = 401) that used the BRAVA system pre-and postoperatively. Due to the heterogeneity among the studies regarding the description of preparation, supplementation, and injection technique, no association could be found concerning volume retention. However, regarding the harvesting technique, most studies reported using either a manual 6, 30 (2 studies, n = 541) or machine-assisted 5,25,36,38,39 (5 studies, n = 355) form of aspiration with volume retentions of 79.0% and 61.0%, respectively (P = <.0001).
Patient/Surgeon Satisfaction
A total of six studies 4, 10, 25, 31, 36, 40 reported on patient and/ or surgeon satisfaction on a 3-to 5-point Likert scale which were manually converted to a 3-point-Likert scale using the conversion model described in Appendix A (available as Supplementary Material at www.aestheticsurgeryjournal. com). Three (n = 529) and four studies (n = 463) reported patient and surgeon satisfaction after AFG, respectively, over a mean follow-up period of 1 year. Patient satisfaction was achieved in 92%, and 89% of the surgical teams reported a good result on postoperative photograms or clinical assessments (Table 7) .
Risk of Bias Across Studies
A comprehensive overview of the risk of bias across the studies is given in Table 1 .
DISCUSSION
We aimed to give a comprehensive overview of the available evidence on the employed techniques and outcomes of AFG in cosmetic breast augmentation. As previously stated, the authors recently published a systematic review using the same methodology but reporting on AFG in addition to onco-plastic breast reconstruction. 28 The latter focuses specifically on the (oncological) safety and efficacy of AFG following various reconstructive techniques, such as myocutaneous flap-and prosthetic reconstruction as well as correction of contour deformities. In this systematic review, following approximately 3400 patients, during a mean follow-up period of 34.5 months, an overall total complication rate of 17.2% (95% CI 15.9-18.5) was found after breast augmentation with AFG. These results are similar to reports of studies with a follow-up period of up to 9 years after implant-based augmentation procedures. 46 However, safety is not only a matter of direct postoperative complications because long-term alterations in breast morphology can present a serious challenge in differentiating benign anomalies from malignancies on radiological examinations. Findings on mammograms, sonograms, and MRIs after AFG treatment appear similar to those findings after other forms of breast surgery. 11, 47, 48 Benign irregularities consisted of cysts, fat necrosis, calcifications, and scar tissue. Cysts are best differentiated from solid masses by way of a sonogram 49 and are described as oval hypoechoic findings, anechoic points, and anechoic areas with regular walls. 43 An MRI is the best method to detect fat necrosis and differentiate it from oil cysts. It is decribed as heterogeneously hyperintense (appearing lighter in color than surrounding tissues) on T2 weighted images (water=bright/fatty content=dark). 50, 51 The presence of decreased signal intensity in the center of fat necrosis is key to differentiating it from a cancerous tumor, which, contrary to fat necrosis, can have a necrotic center. 52, 53 Calcifications after AFG are easily seen on mammograms as white calcium deposits located in the wall of cysts or as coarse irregular spots, sometimes surrounding radiolucent areas of fat necrosis. These benign features are generally easily differentiated from malignant clusters of pleomorphic micro-calcifications on the basis of morphology, size, and distribution. [54] [55] [56] Furthermore, these findings seem to agree with recent large cohort studies 4, 11, 21, 33, 34, 47, 48 that showed that most benign irregularities were easily distinguishable from malignancies as long as good communication exists between the surgeon and radiologist. Fortunately, radio diagnostic techniques and corresponding radiologist experience are continuously improving, enabling radiologists to interpret these findings more and more accurately.
The efficacy of the technique is assessed by retention of the inserted volume and by the satisfaction with the results reported by the patient and surgeon. Eight articles reported an average volume retention of 62.4% (range, 44.7%-82.6%) after a mean follow-up period of 16.6 months. However, it should be noted that six of these articles used an auxiliary method for achieving higher volume rates, as well as retention, which can create a reporting bias since these results are not representative of the volume retention after the solitary use of AFG. Furthermore, the higher volume retention seen after manual aspiration should be interpreted with caution because substantial confounding variables exist. The reported satisfaction was considered high; on average, 92% of the patients and 89% of the surgeons were satisfied with the results. These satisfaction rates after a 1 year follow-up period and in a small cohort of patients seem to surpass those reported after implant-based augmentation procedures. 57 The following two recently published articles are especially worth mentioning in regard to the AFG technique: 1) systematic review by Strong et al, 2 which showed higher retention rates with centrifugation and slow injection of fat and 2) special topic article by Zielins et al, 58 which highlights the latest in vitro, as well as in vivo, findings regarding important steps in the AFG process. In summary, the authors described the perception of a three-zone survival system (ie, surviving, regenerating, and necrotic) when it comes to fat graft survival as previously described by Eto et al 59 The highest yield of AFG volume results from the survival of the regenerating zone, which brings forth ASCs with the potential for differentiation and replacement of "losses" in the necrotic zone, as well as the increased survival through the enhancement of revascularization. Furthermore, these ASCs, as well as the actual adipocytes, seem to thrive on the use of larger cannula sizes for harvesting, as well as injection (5-6 mm), than was previously reported by the ASPS Fat Grafting Task Force (3-4 mm). 60 Another interesting aspect of AFG, as it was thought to make little difference in aesthetic outcomes, 61, 62 is the importance of the donor This percentage was a calculation of the difference in breast thickness (measured in millimeters at 9 o'clock and 3 o'clock direct periareolar) measured by sonogram directly after implant removal compared to the thickness measured at the last follow-up examination. 63 recently reported better volume retention of trochanteric harvested fat, which they attributed to higher numbers of adipocytes and so called "colony forming units." With all of these different aspects, as well as external factors like supplementation (ie, PRP/ SVF) and auxiliary methods (ie, BRAVA system) affecting the outcome, AFG remains a well-studied topic in which much information is yet to be discovered. However, despite all of these advancements, we should remain cautious because several experimental studies still show the potential danger of the interaction between adipose-derived stem cells and mammary epithelial cells, as well as the potential of CD34+ progenitors in white adipose tissue, to promote cancer stimulation/progression. 45, [64] [65] [66] [67] 
Limitations
This systematic review has several limitations. Reported evidence on the outcomes of AFG in cosmetic breast augmentation is still scarce. Only low-level studies (OCEBM III/IV) and mainly retrospective studies without a control group were found. The use of validated measurement tools to assess patient-reported outcomes is lacking, and data on oncological outcomes are absent. Heterogeneity between studies in reported outcomes and nomenclature regarding radiological findings and complications makes it difficult to draw conclusions. This was partly resolved by combining similar terms under one common nominator (eg, oil cysts and lipid cysts), but this may have introduced some bias. The mean volume retention in this review is the outcome of the reported percentages of the remaining volume after the follow-up period in the different studies. The heterogeneity between the studies in calculation of this volume retention can, however, cause a reporting bias. It should also be noted that several studies 6, 21, 33, 37, [39] [40] [41] report outcomes over a mixed cohort of patients without differentiating the outcomes based on indication. Finally, some articles report outcomes over a total cohort of both cosmetic and reconstructive patients. Both factors can independently cause a reporting bias. Therefore, since a systematic review can only be as strong as the articles it includes, certain caution is appropriate when interpreting these results. The aim of this systematic review was to complement the already broad knowledge base on the subject of AFG in cosmetic breast surgery. The authors believe this systematic review accomplishes that by the addition of three recently published studies, [24] [25] [26] as well as the exclusion of case series/ reports and studies with insufficient follow-up periods (specifically for the AFG technique).
CONCLUSIONS
This review provides an updated overview of the important outcomes of AFG for cosmetic breast surgery. Although the evidence is still limited, AFG seems to be a promising method to achieve cosmetic breast augmentation with encouraging volume retention and satisfaction rates in a small number of studies. Complication rates and radiological findings are comparable to those after implant-based augmentation. However, good-quality RCTs are needed to compare augmentation techniques, grafting methods, and use of auxiliary methods to further assess safety and identify which factors affect the outcomes. Also, larger cohorts and longer follow-up periods are necessary to focus on cancer occurrence and detection to further substantiate the safety of this technique. Finally, more objective questionnaires, such as the BREAST-Q, 68 are essential to evaluate patient satisfaction in breast surgery.
